Washington, October 02, 2016: Federal regulators have approved a first-of-a-kind implant that can help some diabetes patients manage their disease, freeing them from the ordeal of constantly monitoring their blood sugar.
The so-called artificial pancreas continuously measures blood sugar and automatically delivers insulin, a hormone needed to turn food into energy.
The device from Medtronic is approved for patients with Type 1 diabetes, a condition diagnosed during childhood that prevents insulin production. Those patients face increased risks of dangerously high blood-sugar levels, heart disease and many other health problems.
Type 1 diabetes patients now have to manage their insulin through injections or a drug pump.
The new MiniMed device consists of a drug pump, a sensor that measures blood sugar and a catheter that delivers the insulin. –ETHealthworld
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…